491
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluation

Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser

, &
Pages 723-733 | Received 29 Jan 2016, Accepted 18 Mar 2016, Published online: 07 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Aleksander Lenert, Timothy B Niewold & Petar Lenert. (2017) Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date. Drug Design, Development and Therapy 11, pages 747-757.
Read now

Articles from other publishers (11)

Giuliana Giardino, Roberta Romano, Vassilios Lougaris, Riccardo Castagnoli, Francesca Cillo, Lucia Leonardi, Francesco La Torre, Annarosa Soresina, Silvia Federici, Caterina Cancrini, Lucia Pacillo, Elisabetta Toriello, Bianca Laura Cinicola, Stefania Corrente, Stefano Volpi, Gian Luigi Marseglia, Claudio Pignata & Fabio Cardinale. (2023) Immune tolerance breakdown in inborn errors of immunity: Paving the way to novel therapeutic approaches. Clinical Immunology 251, pages 109302.
Crossref
Giuliana Giardino, Emilia Cirillo, Rosaria Prencipe, Roberta Romano, Francesca Cillo, Elisabetta Toriello, Veronica De Rosa & Claudio Pignata. 2022. Translational Autoimmunity. Translational Autoimmunity 73 95 .
Marko Kumric, Piero Marin Zivkovic, Tina Ticinovic Kurir, Josip Vrdoljak, Marino Vilovic, Dinko Martinovic, Andre Bratanic, Ivan Kresimir Lizatovic & Josko Bozic. (2021) Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease. Diagnostics 12:1, pages 45.
Crossref
Lin Ning, Bifang He, Peng Zhou, Ratmir Derda & Jian Huang. (2019) Molecular Design of Peptide-Fc Fusion Drugs. Current Drug Metabolism 20:3, pages 203-208.
Crossref
Bimba F. Hoyer & Thomas Dörner. 2019. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes 710 718 .
Srinivasa Reddy Bonam, Fengjuan Wang & Sylviane Muller. (2018) Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option. Journal of Autoimmunity 94, pages 16-32.
Crossref
Frederico Marcondes & Morton Scheinberg. (2018) Belimumab in the treatment of systemic lupus erythematous: An evidence based review of its place in therapy. Autoimmunity Reviews 17:2, pages 103-107.
Crossref
Marina Aparicio-Soto, Marina Sánchez-Hidalgo & Catalina Alarcón-de-la-Lastra. (2017) An update on diet and nutritional factors in systemic lupus erythematosus management. Nutrition Research Reviews 30:1, pages 118-137.
Crossref
Laurie S. Davis & Andreas M. Reimold. (2017) Research and therapeutics—traditional and emerging therapies in systemic lupus erythematosus. Rheumatology 56:suppl_1, pages i100-i113.
Crossref
Ilja Striz. (2016) B Cell-Activating Factor (BAFF) in Inflammatory Bowel Disease: BAFFling No Longer?. Digestive Diseases and Sciences 61:9, pages 2456-2458.
Crossref
A. M. Nicoletti, C. H. Kenny, A. M. Khalil, Q. Pan, K. L. M. Ralph, J. Ritchie, S. Venkataramani, D. H. Presky, S. M. DeWire & S. R. Brodeur. (2016) Unexpected Potency Differences between B-Cell-Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound. Journal of Pharmacology and Experimental Therapeutics 359:1, pages 37-44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.